Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnWeb3SquareMore
Trade
Spot
Buy and sell crypto with ease
Margin
Amplify your capital and maximize fund efficiency
Onchain
Going Onchain, without going Onchain!
Convert
Zero fees, no slippage
Explore
Launchhub
Gain the edge early and start winning
Copy
Copy elite trader with one click
Bots
Simple, fast, and reliable AI trading bot
Trade
USDT-M Futures
Futures settled in USDT
USDC-M Futures
Futures settled in USDC
Coin-M Futures
Futures settled in cryptocurrencies
Explore
Futures guide
A beginner-to-advanced journey in futures trading
Futures promotions
Generous rewards await
Overview
A variety of products to grow your assets
Simple Earn
Deposit and withdraw anytime to earn flexible returns with zero risk
On-chain Earn
Earn profits daily without risking principal
Structured Earn
Robust financial innovation to navigate market swings
VIP and Wealth Management
Premium services for smart wealth management
Loans
Flexible borrowing with high fund security
Tether Pumps $200M Into Biotech Firm as ‘Tether Evo’ Takes Off

Tether Pumps $200M Into Biotech Firm as ‘Tether Evo’ Takes Off

DailyCoinDailyCoin2024/04/30 03:19
By:DailyCoin
  • Tether has announced a new strategic investment.
  • The investment was made through the company’s newly formed division.
  • The new division seeks to bridge the gap between humans and technology.

The company said that USDT stablecoin issuer Tether has acquired the majority stake in Blackrock Neurotech through a multimillion-dollar investment.

Founded in 2008 by Dr. Florian Solzbacher and Marcus Gerhardt, Blackrock Neurotech has established itself as a leader in neuroscience, neural engineering, and neural prosthetics. The company is also a leading pioneer in Brain-Computer Interface (BCI) technology.

Read More

Tether Secures Strategic Stake in Blackrock Neurotech

According to an announcement dated April 29, Tether is now the majority stakeholder in Blackrock Neurotech following a $200 million investment into the company through its newly formed venture division, Tether Evo.

Sponsored

Like its other divisions, such as Tether Edu and Tether Power, Tether Evo aims to expand Tether’s focus beyond stablecoin offerings. The division “stands at the intersection of innovation and human potential,” Tether said.

With the investment, Blackrock Neurotech is keen on commercializing and rolling out its innovative medical solutions that have already been “successfully applied to more than 40 individuals.”

“The investment will also be used to further boost Blackrock Neurotech’s RD efforts to ensure that they remain the leading BCI company now and in the future, with a long term focus on human evolution and enhancement of our species’ potential through a safe bridge between the human brain and artificial intelligence computing,” the statement read.

Tether CEO Paolo Ardoino lauded the move, noting that it was the beginning of the company’s journey through Tether Evo to venture into projects that redefine the boundaries of human and tech intersection. Ardoino clarified that the investment was made outside stablecoin reserves with “own company profits.”  

Sponsored

Read about Tether’s recent company restructuring:
Tether Announces Company Restructuring for Broader Crypto Play

Stay updated on Tether’s recent SOC 2 Type 1 audit:
Tether Reaffirms Security Compliance with SOC 2 Type 1 Audit

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!